About us

Broken String Biosciences is building a technology platform that accelerates the characterisation of novel genome editing technologies. This will unlock the next wave of cell & gene therapies.

Our vision is a future where cell & gene therapies are safer, more efficient, and affordable for patients. Starting with our DNA break mapping technology INDUCE-seq™, our data-driven platform reveals precisely how genome editors interact with and alter our genomes. This information is essential for the efficient development of novel genome editing systems and will unlock many new targets within the genome for therapeutic development.

Broken String Biosciences is backed by Illumina and Tencent and is based at the Wellcome Genome Campus, Cambridge, UK.



INDUCE-seq™ is a game changing technology for the characterisation of genome breaks in cell & gene therapy applications.

Read more about INDUCE-seq™ in Nature Communications

Get in touch to find out more about how INDUCE-seq™ can empower your cell & gene therapy development process.


We are building partnerships with scientific leaders and world-renowned organisations.

Integrated DNA Technologies
UK Regenerative Medicine Platform

Interested in joining our team?

Come and join our dynamic and growing team to share in our vision of delivering on the promise of
gene editing


All News